Deal Capsule - October 2017 | KPMG | DE

Deal Capsule - October 2017

Deal Capsule - October 2017

M&A activity remains solid in life sciences.

1000

Contact

Partner, Head of Chemicals & Pharmaceuticals

KPMG AG Wirtschaftsprüfungsgesellschaft

Contact

Related content

Reagenzgläser

Theme of this issue:

M&A activity remains solid in life sciences with a high number of announced deals, although deal values are not expected to hit the heady levels of 2014 and 2015. Oncology drives M&A in life sciences as key players seek to optimize their portfolios in anticipation of 10.9% CAGR growth to 2030. Chemical companies are increasingly focussing their M&A on application industries. Agrochemicals remains an M&A hotspot. The closing of the DowDuPont merger brought with it a spate of anti-trust divestments. US and China remain the most active countries in both sectors.

Online version

Browse directly through the publication

KPMG Deal Capsule Newsletter

Connect with us

 

Request for proposal

 

Submit